Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Man Trial to Investigate Safety and Efficacy of the New IgE Adsorber

NCT02096237 is registered in ClinicalTrials.gov with Fresenius Medical Care Deutschland GmbH as lead sponsor.

NCT NCT02096237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02096237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Man Trial to Investigate Safety and Efficacy of the New IgE Adsorber
Lead sponsor
Fresenius Medical Care Deutschland GmbH
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
November 30, 2014
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma